US Bancorp DE reduced its position in Mead Johnson Nutrition Co. (NYSE:MJN) by 18.5% during the third quarter, Holdings Channel reports. The firm owned 133,278 shares of the company’s stock after selling 30,295 shares during the period. US Bancorp DE’s holdings in Mead Johnson Nutrition were worth $10,531,000 as of its most recent filing with the SEC.

A number of other large investors have also recently made changes to their positions in MJN. LPL Financial LLC raised its stake in shares of Mead Johnson Nutrition by 0.7% in the first quarter. LPL Financial LLC now owns 13,023 shares of the company’s stock worth $1,086,000 after buying an additional 91 shares during the period. Babson Capital Management LLC raised its stake in shares of Mead Johnson Nutrition by 469.2% in the first quarter. Babson Capital Management LLC now owns 21,836 shares of the company’s stock worth $1,855,000 after buying an additional 18,000 shares during the period. First Republic Investment Management Inc. raised its stake in shares of Mead Johnson Nutrition by 11.6% in the first quarter. First Republic Investment Management Inc. now owns 11,107 shares of the company’s stock worth $944,000 after buying an additional 1,156 shares during the period. Baxter Bros Inc. purchased a new stake in shares of Mead Johnson Nutrition during the second quarter worth about $218,000. Finally, British Columbia Investment Management Corp raised its stake in shares of Mead Johnson Nutrition by 26.2% in the second quarter. British Columbia Investment Management Corp now owns 149,740 shares of the company’s stock worth $13,589,000 after buying an additional 31,099 shares during the period. 94.72% of the stock is currently owned by institutional investors and hedge funds.

Institutional Ownership by Quarter for Mead Johnson Nutrition (NYSE:MJN)

Shares of Mead Johnson Nutrition Co. (NYSE:MJN) traded down 0.531% on Wednesday, reaching $72.125. 682,612 shares of the company’s stock traded hands. Mead Johnson Nutrition Co. has a 12-month low of $65.53 and a 12-month high of $94.40. The company has a market cap of $13.32 billion, a PE ratio of 26.802 and a beta of 1.43. The stock has a 50-day moving average price of $75.58 and a 200-day moving average price of $82.43.

Mead Johnson Nutrition (NYSE:MJN) last posted its quarterly earnings results on Thursday, October 27th. The company reported $0.87 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.86 by $0.01. The company had revenue of $937.50 million for the quarter, compared to the consensus estimate of $933.43 million. Mead Johnson Nutrition had a net margin of 13.26% and a negative return on equity of 119.05%. The firm’s revenue was down 4.1% compared to the same quarter last year. During the same quarter last year, the firm posted $0.77 EPS. Equities research analysts anticipate that Mead Johnson Nutrition Co. will post $3.45 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “US Bancorp DE Has $10,531,000 Position in Mead Johnson Nutrition Co. (MJN)” was originally published by Daily Political and is the sole property of of Daily Political. If you are reading this piece of content on another website, it was copied illegally and republished in violation of US & international copyright laws. The original version of this piece of content can be accessed at http://www.dailypolitical.com/2016/11/30/us-bancorp-de-has-10531000-position-in-mead-johnson-nutrition-co-mjn.html.

A number of equities research analysts have recently weighed in on the stock. raised shares of Mead Johnson Nutrition from an “underperform” rating to an “outperform” rating and set a $96.00 target price on the stock in a research note on Wednesday, August 3rd. JPMorgan Chase & Co. reaffirmed an “overweight” rating and set a $105.00 target price on shares of Mead Johnson Nutrition in a research note on Friday, August 5th. Susquehanna reaffirmed a “hold” rating on shares of Mead Johnson Nutrition in a research note on Monday, August 8th. Citigroup Inc. cut their target price on shares of Mead Johnson Nutrition from $106.00 to $103.00 and set a “buy” rating on the stock in a research note on Thursday, September 8th. Finally, Credit Suisse Group AG set a $100.00 target price on shares of Mead Johnson Nutrition and gave the company a “buy” rating in a research note on Monday, September 12th. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus target price of $88.33.

In related news, Director Anna C. Catalano sold 656 shares of the firm’s stock in a transaction dated Monday, October 31st. The shares were sold at an average price of $74.99, for a total value of $49,193.44. Following the transaction, the director now owns 8,796 shares of the company’s stock, valued at approximately $659,612.04. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 0.50% of the stock is currently owned by corporate insiders.

Mead Johnson Nutrition Company Profile

Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Company operates through three segments: Asia, North America/Europe and Latin America. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders.

5 Day Chart for NYSE:MJN

Want to see what other hedge funds are holding MJN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mead Johnson Nutrition Co. (NYSE:MJN).

Receive News & Ratings for Mead Johnson Nutrition Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mead Johnson Nutrition Co. and related companies with MarketBeat.com's FREE daily email newsletter.